Is there a generic for Levallorphan tartrate?

The FDA Orange Book does not currently list an approved generic (ANDA) for Levallorphan tartrate. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Levallorphan tartrate?

LORFAN (NDA 010423, ROCHE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Levallorphan tartrate are approved?

Levallorphan tartrate is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Levallorphan tartrate

Levallorphan tartrate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:LORFAN · NDA 010423

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
LORFAN	ROCHE	NDA 010423	—	Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Levallorphan tartrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo